News & Articles

Accuracy in ESR1 mutation testing means the difference between treatment and resistance — now a new ESR1 control kit ensures reliable results

Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast

AISight Dx now supports VENTANA DP 200 and DP 600 slide scanners for pathology laboratories

New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research

The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions

Guest editorial by Dale Powner, Country Manager for the UK, Ireland and Nordics at Binding Site, part of Thermo Fisher Scientific

With antimicrobial resistance on the rise, rapid AST offers a lifeline for critically ill patients and supports improved antibiotic stewardship

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

One lab shares its experience boosting efficiency and accuracy with StatLab’s PiSmart Cassette and Slide printers

One lab shares its experience switching to Streck’s quality control solution for molecular diagnostics testing

Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC

Enabling accurate and accessible ethyl alcohol testing across moderate complexity laboratories

Initiative to expand testing access to underserved U.S. communities

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics

Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025

Understaffing in the lab threatens the collaboration doctors depend on

AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease

46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits

First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

New findings at ADLM 2025 could remedy this failure

Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025